By Megan Rychwa, Investor Research Analyst, LSN

Life Science Nation’s last conference of the year, Digital RESI November 16-18, is currently accepting applications from startup companies across the globe for the popular Innovator’s Pitch Challenge (IPC). The number of participating startups has doubled within the last year, with hundreds of companies and investors experiencing the value firsthand. Applications are accepted on a rolling basis until Friday, October 22.

The Innovator’s Pitch Challenge is an opportunity for early-stage companies to pitch to a live panel of investors within their sector. Each company’s marketing materials are highlighted on their dedicated webpage, as well as their recorded pitch, which investors can see prior to the conference in preparation for the live event. The pitch session is a unique chance for companies to gain exposure to a large investor audience and prepare those companies to build strategic partnerships with well-matched investors. The cost for IPC finalists includes event registration, as well as a $500 pitch fee.

The deadline for IPC applications is tomorrow, so make sure your application is in and you don’t miss out on this great opportunity to tell your story!

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Bright-eyed entrepreneurs with big ideas and even bigger fundraising needs have joined Digital RESI throughout 2021 in hopes of meeting investors who are just as excited to meet them, and there’s no virtual meeting spot that brings the two together like the Innovator’s Pitch Challenge (IPC). Apply to pitch at DIgital RESI November by October 22!

The IPC provides opportunities for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session. Fundraising entrepreneurs use the IPC for exposure, connection, valuable feedback, and often, a conversation that leads to many more down the road. Investors use it for the same – the opportunity to hear from and connect with entrepreneurs, learn more about exciting technology, and advance deal-flow initiatives.

For these reasons, the IPC is one of the most popular and well-attended features of the Digital RESI conference series, but don’t take our word for it. See what investors have said about their participation and check out previous investors that have sat on IPC judging panels throughout 2021.

“It was a very economical use of time; the investors got to ask their important questions and the Innovators got a good idea of the most pressing questions from the investors point of view.” William Kuziel, MedPro Investors “The Pitch Sessions are a great opportunity to connect with startup CEOs and learn more about their work…It really has been an effective and efficient way to make connections, create deal flow and help startups raise money for their upcoming raises.” Mayank Taneja, OSF Healthcare “I look forward to LSN’s events because they provide an opportunity for our venture capital firm to find promising companies with exceptional technologies. The organization and technology platform make it very easy to hear numerous pitches from founders.” Nat Brinn, VC23 “The Pitch Sessions were a great opportunity to engage with the CEO/Founders of very innovative Life Science startups. Despite the COVID-related transition from in-person to virtual meetings, the RESI team did an outstanding job organizing these sessions, ensuring that the live Q&A was very productive, and facilitating follow-up with these exciting companies.” Gary Gershony, Life Science Angels / BayMed Venture Partners

Hamzeh Abdul-Hadi Hikma Ventures	Aiden Aceves Vida Ventures	Nuno Afonso Apogee Ventures	Brent Ahrens Canaan Partners
Alexandra Amen BridgeBio	Richard Anders Mass Medical Angels	Bauke Anninga M Ventures	Marc Appel Orange Grove Bio
Anjan Aralihalli CTI Life Sciences Fund	Aimee Barkway Hadean Ventures	Amine Benmoussa Apogee Ventures	Attila Berces FastVentures
Sascha Berger TVM Capital Life Science	Randy Berholtz Mesa Verde Venture Partners	Reetika Bhardwaj ARCH Venture Partners	Ivneet Bhullar Fusion Fund
Yoann Bonnamour Mérieux Equity Partners	Todd Brady Brace Pharma Capital	Nat Brinn VC23	Ivan Burkov INKEF Capital
Cynthia Cai Viva BioInnovator	Valerie Calenda Mérieux Equity Partners	Anke Cassing High-Tech Gründerfonds	Jeremy Chang BridgeBio
Benjamin Chen Panacea Ventures	Kenneth Chew Vickers Venture Partners	Poh Hui Chia Vickers Venture Partners	Chinmay Chinmay BioIdeations
Elizabeth Cho-Fertikh Meda Angels	Michel Chu Acorn Campus Taiwan	Pablo Cironi Caixa Capital Risc	Barbara Clarke Astia Angels
Darren Cooke Life Science Angels	Peter Crane Outsized Ventures	David Crean Mesa Verde Venture Partners	Ruchi Dana Dana Group
Aldemar Degroot Biogen	Niels Emmerich AbbVie Inc.	Bettina Ernst BERNINA BioInvest	Jemima Escamilla Research Corporation Technologies
Naomi Fried Ambit Health Ventures	Ryo Fujinami Shinsei Capital Partners	Robert Garber 7wire Ventures	Gary Gershony BayMed Venture Partners
Tom Gibbs Debiopharm Innovation Fund	Sam Goldberger Ambit Health Ventures	Gage Greening Medical Technology Enterprise Consortium (MTEC)	Bryan Grulke Volcano Capital
Brian Hakim MedtecX	Elaine Hamm Ascend BioVentures	Z Haroon Julz Co LLC	Christopher Haskell, Ph.D. Bayer
Michelle Ho 5AM Ventures	Vivien Ho Pear Ventures	Alan Hochberg Roche	Dave Hood Medical Technology Enterprise Consortium (MTEC)
Dmitrij Hristodorov Forbion Capital Partners	Adam Hunke Banner Venture Group	Tomoko Ishikura Kicker Ventures	Mishael Zohar OrbiMed Advisors LLC
I-Chien Jan Hukui Bio	Allan Johnston Synergy Ventures	Rick Jones BioAdvance	Patrick Keenan Prevail Partners
Faisal Khan AstraZeneca	John Kim Aphelion Capital, LLC	Kristin King Boston Harbor Angels	Merom Klein Keiretsu Forum
Pascal Krotee RiverVest Venture Partners	Dmitry Kuzmin 4Bio Capital Partners	Sebastien Latapie Dynamk Capital	Zachary Leach Catalyst Health Ventures
Carla Lema Tomé Otsuka Pharmaceutical	Elliot Levy DreamIt Health	George Li Proxima Ventures	Yatong Li Sixty Degree Capital
Xinhong Lim Vickers Venture Partners	Debbie Lin Boehringer Ingelheim Venture Fund	Don Lin Guoqian Venture Capital Investment	Henry Lu China Merchants Capital
Benedikt Luhmann VI Partners	Marc Martin-Casas Illumina Accelerator	Tai Mei Meda Angels	Andy Merken Burns & Levinson
Wouter Meuleman Illumina Ventures	Junaid Mian SP8CEVC	Sergio Montero Start-Up Chile	Walter Moos Pandect Bioventures
Anesa Mulabecirovic Hadean Ventures	Kim Nearing BVCF	Justin Norden GSR Ventures	Cédric Odje Debiopharm Innovation Fund
Michael O’Donnell Life Science Angels	Marion Paolini Servier	Nami Park Life Science Angels	Francoise Perron-Sierra Servier
Dave Pinkowitz AnPac Bio	Rohit Pratap Singh Xeraya Capital	Mark Ralph Boehringer Ingelheim Venture Fund	Varun Ramdevan Johnson & Johnson Innovation
David Ramos iGan Partners	Richard Reschen MSD	Stella Robertson Bios Partners	Mel Rothberg Mira Life Science Ventures
Nikhil Sadhwani Individual Angel	Caroline Sai Angels Santé	Christina Salys Intuitive Surgical	Diana Saraceni Panakes Partners
Barbara Schilberg BioAdvance	Steve Seuntjens Personal Health Solutions	Bryan Shao Keiretsu Forum	Niels Sharman High-Tech Gründerfonds
Megan Shaw Innovation Works	David Siet Amzak Health	Mira Sirotic Keiretsu Forum	Catello Somma TVM Capital Life Science
Jill Sorensen Medical Technology Enterprise Consortium (MTEC)	Adarsh Sowcar NOVA	Karen Spilizewski RiverVest Venture Partners	Mark Springel Vida Ventures
Sanjay Srinivasan Accent Advisors	Eran Steinberg Imaging Arts	Kevin Sterling Keiretsu Forum	Weiyong Sun Daiichi Sankyo
Ben Sun Sand Hill Angels	Haolin Sung Chaperone Investment	Gayathri Swaminath GreenFire Bio, LLC	Mayank Taneja OSF Healthcare Ventures
Mark Tang Good Health Capital	Liz Todia Mutual Capital Partners	Gadi Toren Robert Bosch Venture Capital	Bill Trainor Mutual Capital Partners
Robert Tucci Texas Halo Fund	Thomas Vogelsong KYTO Technology and Life Science	Tad Weems Agilent Technologies	Scott Weiner Amzak Health
Travis Whitfill Bios Partners	Thierry Wurch Ipsen S.A.	Jonathan Yeh Saisei Ventures	John Yianni Earlybird
Alicia Yin 6 Dimensions Capital	Derek Yuan LYFE Capital	Yanxiang Zhou Illumina Ventures	Anthony Zlaket UnityPoint Health Ventures